Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check27 days agoChange DetectedThe date on the webpage has been updated from April 9, 2025, to April 20, 2025.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated to reflect a new version, v2.15.0, and the date has been changed to April 9, 2025. The previous version, v2.14.4, and the date March 13, 2025, have been removed.SummaryDifference2%
- Check42 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 13, 2025.SummaryDifference0.7%
- Check64 days agoChange DetectedThe date has been updated from February 28, 2025, to March 13, 2025.SummaryDifference0.7%
- Check78 days agoChange DetectedThe date has been updated from June 4, 2024, to February 28, 2025.SummaryDifference1.0%
Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.